Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
94.3%
% of IHE's 36 holdings also in XPH
80.5%
% of XPH's 41 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
VIATRIS, INC. | 4.9% | 4.4% | 4.4% |
|
PFIZER INC | 4.8% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 23.5% | 4.0% | 4.0% |
|
ZOETIS INC | 4.5% | 3.9% | 3.9% |
|
ROYALTY PHARMA PLC CLASS A | 4.4% | 3.9% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to XPH
|
JOHNSON & JOHNSON | 19.5% |
|
ELI LILLY & CO | 18.2% |
|
PFIZER INC | 0.7% |
|
MERCK & CO. INC. | 0.6% |
|
BRISTOL-MYERS SQUIBB CO | 0.6% |
|
ZOETIS INC | 0.6% |
|
VIATRIS, INC. | 0.6% |
|
ROYALTY PHARMA PLC CLASS A | 0.5% |
|
CATALENT INC | 0.3% |
|
REVANCE THERAPEUTICS INC | 0.2% |
IHE Underweight Relative to XPH
|
AXSOME THERAPEUTICS, INC. | -3.0% |
|
ARVINAS, INC. | -2.7% |
|
OCULAR THERAPEUTIX INC | -2.6% |
 |
PERRIGO CO | -2.4% |
|
CORCEPT THERAPEUTICS INC | -2.4% |
|
LONGBOARD PHARMACEUTICALS, INC. | -1.9% |
|
ORGANON & CO. | -1.7% |
|
TARSUS PHARMACEUTICALS, INC. | -1.6% |
|
AMPHASTAR PHARMACEUTICALS INC | -1.5% |
|
SUPERNUS PHARMACEUTICALS INC | -1.5% |